Business
LEVBIO: Platform upgrades, Q4 pilot, and lab partnerships drive ongoing business development
LEVBIO: Platform upgrades, Q4 pilot, and lab partnerships drive ongoing business development
About this update from Level Bio Ab
Platform enhancements and new business initiatives are underway, including a Q4 pilot and lab partnerships. Key metrics such as 70% and 46% were mentioned, with ongoing capital allocation and business development efforts.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.